MajorVitaman
Superstar

Market Research Reports | Procurement Research Reports | IBISWorld US
ADHD Medication Manufacturing in the US: Market Research Report
Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends
ADHD Medication Manufacturing Market Research Report | Life Sciences | Prescription Drugs | Feb 2015
In good health: Wider recognition and increasing health reforms will support the industry
The ADHD Medication Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.
Market Share of Companies
Shire Pharmaceuticals

Industry Statistics & Market Size
Revenue
$13bn
Annual Growth 10-15
8.0%
Annual Growth 15-20

Profit

Employment
14,734
Businesses
196
Industry Analysis & Industry Trends
The use of medication for the treatment of attention deficit disorders, such as ADHD, is growing. The recent recognition of ADHD as a condition that can also afflict adults has provided a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to 2020, industry revenue will continue to grow as the trends from the previous five years bolster utilization rates. However, many brand-name drugs are set to lose their patent exclusivity, which will incite more generic drug manufacturers to inundate the market with low-cost drugs, intensifying price-based competition....purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The ADHD Medication Manufacturing industry is currently in the growth life cycle stage. During the 10 years to 2020, industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 7.3%. Comparatively, US GDP is anticipated to grow at an average annual rate of 2.5% over the same period. According to data from Healthline, the number of individuals treated for ADHD in the United States has skyrocketed 42.0% over the past eight years, which has provided a boon to the industry. Further benefiting the industry, in 2013, the American Psychiatric Association established guidelines for healthcare providers to diagnose adults with ADHD... purchase to read more


This is the numbers for just ADHD drugs like Adderall...


Combination of
amphetamine aspartate monohydrate (25%) stimulant
amphetamine sulfate (25%) stimulant
dextroamphetamine saccharate (25%) stimulant
dextroamphetamine sulfate (25%) stimulant



Any Pharmacy, Khemistry, Doctor, Alkhemy brehs/brehettes in the field know more about the business? Cacs are eating real good off this legal amphetamines hustle

Imagine how much they're making on xans, lean & percs.

Coli, how can we get a piece of this pie? Baby boomers steady hitting that

